1,3-dipropyl-8-cyclopentylxanthine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrante, A | 1 |
| Martire, A | 1 |
| Pepponi, R | 1 |
| Varani, K | 1 |
| Vincenzi, F | 1 |
| Ferraro, L | 1 |
| Beggiato, S | 1 |
| Tebano, MT | 1 |
| Popoli, P | 1 |
| Alfinito, PD | 1 |
| Wang, SP | 1 |
| Manzino, L | 1 |
| Rijhsinghani, S | 1 |
| Zeevalk, GD | 1 |
| Sonsalla, PK | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
Topics: Action Potentials; Adenine; Adenosine A1 Receptor Antagonists; Animals; Cerebral Cortex; Corpus Stri | 2014 |
Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Corpus Str | 2003 |